From Sell-Down Overhang to Heavy Institutional Holdings: Shoucheng Holdings (0697.HK) Upgrades Its Shareholder Structure and Opens the Door to Value Re-Rating
Sigenergy Passes Hearing: “AI + Energy Storage” Driving a 150-fold Revenue Surge and Redefining Industry Growth
Haitian Flavouring Releases 2025 Annual Results: Multi-Dimensional Category Growth + Accelerated Globalization – High-Quality Growth Highlights Long-Term Value
Shoucheng Holdings (0697.HK) Reports Approximately 37% Year-on-Year Growth in Industrial Fund Revenue, with Its Dual-Core Businesses Opening Up New Space for Earnings Realization
From Parking Fees to ‘Mother Port’ Services for Autonomous Vehicles, Shoucheng Holdings (0697.HK) Is Rewriting the Business Model of Parking Lots
Shoucheng Holdings (697.HK) Sees an Inflection Point Approaching for REITs and Plans to Substantially Scale Up Investment in 2026
Behind the Fourfold Growth of the Beijing Robotics Fund in Four Years: Shoucheng Holdings (0697.HK) Locks In Its Position at the Infrastructure Gateway for Robotics Commercialization
From Parking Lots to Robot Hubs: Shoucheng Holdings (0697.HK) Redefines Static Transport Infrastructure Through Asset Management Logic
Ausnutria 2025 Annual Results: Revenue Powered by International Business and Family Nutrition, Lean Management Underpins Operational Resilience
Shoucheng Holdings (0697.HK) Proposes HK$780 Million Dividend: HK$6 Billion in Cumulative Payouts Over Eight Years Solidifies Long-Term Value Logic
Xunce Technology’s Revenue Surges 449% Half-on-Half: Is a Structural Revaluation to a Hundred-Billion Market Cap Camp on the Horizon?
Analogue 2025 Annual Results Profit Attributable to Owners of the Company Increases 23.5% to HK$167.0 Million
Modern Dental Group Announces 2025 Annual Results, Net Profit Surges 47.7% on Digitalization-Driven Operational Efficiency Gains
JF SmartInvest Holdings Ltd Adjusted Profit Leaps 191.8% to RMB1.02 Billion ‘Technology + Investment Research’ Dual-Driver Strategy Delivers Remarkable Results, Overseas Expansion Ushers in a New Chapter of Globalisation
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
